Related Experiment Video
Updated: Jul 10, 2026
05:21
Laparoscopic Extracorporeal Knot-Tying for Uterine Vessel Occlusion during Hysterectomy with Cervical Cerclage in Large Uteri
Published on: September 12, 2025
Cervical priming with misoprostol prior to transcervical procedures
C Fiala1, K Gemzell-Danielsson, O S Tang
1Gynmed Clinic, Vienna, Austria. christian.fiala@aol.at
Summary
Cervical priming with misoprostol effectively prepares the cervix for procedures like surgical abortion and hysteroscopy. A single 400 microgram dose, administered sublingually or vaginally 3 hours prior, offers the best balance of efficacy and minimal side effects.
Area of Science:
- Gynecology
- Pharmacology
Background:
- Cervical priming with misoprostol facilitates transcervical procedures.
- It is recommended by evidence-based guidelines for various gynecological interventions.
- Misoprostol is a suitable prostaglandin due to its favorable pharmacokinetic and stability profile.
Purpose of the Study:
- To review the efficacy and safety of misoprostol for cervical priming.
- To determine optimal dosing, route, and timing for misoprostol administration.
- To evaluate side effects associated with misoprostol use.
Main Methods:
- Review of existing literature on misoprostol for cervical priming.
- Analysis of various doses, routes of administration, and time intervals.
- Evaluation of clinical outcomes and reported side effects.
Main Results:
- A single 400 microgram dose of misoprostol, given sublingually or vaginally 3 hours before a procedure, demonstrates optimal efficacy.
- Higher doses or longer intervals do not enhance cervical preparation.
- Pain is a common side effect, manageable with NSAIDs; other side effects are rare.
Conclusions:
- Cervical priming with misoprostol is effective for transcervical procedures in both pregnant and non-pregnant women.
- The optimal regimen involves a single 400 microgram dose 3 hours pre-intervention.
- Misoprostol offers a safe and cost-effective option for cervical preparation.
